Identification of TAPBPL as a novel negative regulator of T‐cell function

Abstract T cell stimulatory and inhibitory molecules are critical for the regulation of immune responses. In this study, we identify a novel T cell co‐inhibitory molecule TAPBPL, whose amino acid sequence shares homology with known B7 family members. TAPBPL protein is expressed on resting and activa...

Full description

Bibliographic Details
Main Authors: Yujun Lin, Cheng Cui, Min Su, Lawrence K Silbart, Haiyan Liu, Jin Zhao, Lang He, Yuanmao Huang, Dexin Xu, Xiaodan Wei, Qian Du, Laijun Lai
Format: Article
Language:English
Published: Springer Nature 2021-05-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202013404
_version_ 1797282171377942528
author Yujun Lin
Cheng Cui
Min Su
Lawrence K Silbart
Haiyan Liu
Jin Zhao
Lang He
Yuanmao Huang
Dexin Xu
Xiaodan Wei
Qian Du
Laijun Lai
author_facet Yujun Lin
Cheng Cui
Min Su
Lawrence K Silbart
Haiyan Liu
Jin Zhao
Lang He
Yuanmao Huang
Dexin Xu
Xiaodan Wei
Qian Du
Laijun Lai
author_sort Yujun Lin
collection DOAJ
description Abstract T cell stimulatory and inhibitory molecules are critical for the regulation of immune responses. In this study, we identify a novel T cell co‐inhibitory molecule TAPBPL, whose amino acid sequence shares homology with known B7 family members. TAPBPL protein is expressed on resting and activated T cells, B cells, monocytes, and dendritic cells (DCs), as well as on some tumor tissues. The putative TAPBPL receptor is expressed on activated CD4 and CD8 T cells. A soluble recombinant human TAPBPL‐IgG Fc (hTAPBPL‐Ig) fusion protein inhibits the proliferation, activation, and cytokine production of both mouse and human T cells in vitro. In vivo administration of hTAPBPL‐Ig protein attenuates experimental autoimmune encephalomyelitis (EAE) in mice. Furthermore, an anti‐TAPBPL monoclonal antibody neutralizes the inhibitory activity of hTAPBPL‐Ig on T cells, enhances antitumor immunity, and inhibits tumor growth in animal models. Our results suggest that therapeutic intervention of the TAPBPL inhibitory pathway may represent a new strategy to modulate T cell‐mediated immunity for the treatment of cancer, infections, autoimmune diseases, and transplant rejection.
first_indexed 2024-03-07T17:09:09Z
format Article
id doaj.art-c39273ccefc141c486e0755f1dbd8b8b
institution Directory Open Access Journal
issn 1757-4676
1757-4684
language English
last_indexed 2024-03-07T17:09:09Z
publishDate 2021-05-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj.art-c39273ccefc141c486e0755f1dbd8b8b2024-03-03T02:17:20ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842021-05-01135n/an/a10.15252/emmm.202013404Identification of TAPBPL as a novel negative regulator of T‐cell functionYujun Lin0Cheng Cui1Min Su2Lawrence K Silbart3Haiyan Liu4Jin Zhao5Lang He6Yuanmao Huang7Dexin Xu8Xiaodan Wei9Qian Du10Laijun Lai11Department of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USADepartment of Allied Health Sciences University of Connecticut Storrs CT USAPlant Biology Section Cornell University Ithaca NY USADepartment of Allied Health Sciences University of Connecticut Storrs CT USAAbstract T cell stimulatory and inhibitory molecules are critical for the regulation of immune responses. In this study, we identify a novel T cell co‐inhibitory molecule TAPBPL, whose amino acid sequence shares homology with known B7 family members. TAPBPL protein is expressed on resting and activated T cells, B cells, monocytes, and dendritic cells (DCs), as well as on some tumor tissues. The putative TAPBPL receptor is expressed on activated CD4 and CD8 T cells. A soluble recombinant human TAPBPL‐IgG Fc (hTAPBPL‐Ig) fusion protein inhibits the proliferation, activation, and cytokine production of both mouse and human T cells in vitro. In vivo administration of hTAPBPL‐Ig protein attenuates experimental autoimmune encephalomyelitis (EAE) in mice. Furthermore, an anti‐TAPBPL monoclonal antibody neutralizes the inhibitory activity of hTAPBPL‐Ig on T cells, enhances antitumor immunity, and inhibits tumor growth in animal models. Our results suggest that therapeutic intervention of the TAPBPL inhibitory pathway may represent a new strategy to modulate T cell‐mediated immunity for the treatment of cancer, infections, autoimmune diseases, and transplant rejection.https://doi.org/10.15252/emmm.202013404autoimmune diseaseB7 familyT cellsTAPBPLtumor immunity
spellingShingle Yujun Lin
Cheng Cui
Min Su
Lawrence K Silbart
Haiyan Liu
Jin Zhao
Lang He
Yuanmao Huang
Dexin Xu
Xiaodan Wei
Qian Du
Laijun Lai
Identification of TAPBPL as a novel negative regulator of T‐cell function
EMBO Molecular Medicine
autoimmune disease
B7 family
T cells
TAPBPL
tumor immunity
title Identification of TAPBPL as a novel negative regulator of T‐cell function
title_full Identification of TAPBPL as a novel negative regulator of T‐cell function
title_fullStr Identification of TAPBPL as a novel negative regulator of T‐cell function
title_full_unstemmed Identification of TAPBPL as a novel negative regulator of T‐cell function
title_short Identification of TAPBPL as a novel negative regulator of T‐cell function
title_sort identification of tapbpl as a novel negative regulator of t cell function
topic autoimmune disease
B7 family
T cells
TAPBPL
tumor immunity
url https://doi.org/10.15252/emmm.202013404
work_keys_str_mv AT yujunlin identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT chengcui identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT minsu identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT lawrenceksilbart identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT haiyanliu identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT jinzhao identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT langhe identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT yuanmaohuang identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT dexinxu identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT xiaodanwei identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT qiandu identificationoftapbplasanovelnegativeregulatoroftcellfunction
AT laijunlai identificationoftapbplasanovelnegativeregulatoroftcellfunction